Nohla has raised a total of $111 million toward improving the use of umbilical cord blood instead of bone marrow in stem-cell transplants to treat cancer and other diseases.

Seattle Biz Journal
Nohla adds million in funding and three new investors

Stay Current On Entrepreneurship

One email per week, all the latest content from the top rising business owners